Fig. 4From: Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort studyKaplan-Meier survival analyses of the patients divided into groups by skeletal muscle index change by cut-off of − 5%. a Shows the 2-year overall survival rates between the groups and b shows the 2-year recurrence free survivalBack to article page